Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Pretreatment of RBCs for use in RBC antibody detection, identification, and/or compatibility testing; incubation with chemical agents or drugs, each

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 86970 refers to the pretreatment of red blood cells (RBCs) specifically for the purposes of detecting, identifying, and/or testing compatibility for RBC antibodies. This procedure involves incubating the red blood cells with various chemical agents or drugs, which is crucial for analyzing the reaction that occurs. The primary goal of this process is to ascertain whether a specific drug is present in the bloodstream, particularly after a blood sample has tested positive for an antibody related to that drug. This testing is essential in transfusion medicine and helps ensure patient safety by identifying potential adverse reactions to transfused blood products. It is important to note that if the sample undergoes treatment with enzymes prior to examination, the appropriate code to use would be 86971. Additionally, if the components of the blood are separated before conducting the test, the correct code would be 86972. This structured approach to testing allows healthcare professionals to make informed decisions regarding patient care and treatment options.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 86970 is indicated in specific clinical scenarios where the detection of antibodies against red blood cells is necessary. The following conditions warrant the use of this procedure:

  • Antibody Detection This procedure is performed when there is a need to identify the presence of antibodies in a patient's blood that may react with red blood cells, particularly after a positive screening for such antibodies.
  • Compatibility Testing It is indicated for compatibility testing prior to blood transfusions, ensuring that the donor blood is safe for the recipient by confirming the absence of harmful antibody reactions.
  • Drug Interaction Assessment The procedure is also indicated when assessing potential interactions between drugs and red blood cells, particularly in patients who have had adverse reactions to medications.

2. Procedure

The procedure for CPT® Code 86970 involves several critical steps to ensure accurate results in the detection and identification of RBC antibodies. The following procedural steps are outlined:

  • Step 1: Sample Collection A blood sample is collected from the patient, typically via venipuncture, ensuring that the sample is handled according to standard laboratory protocols to maintain its integrity.
  • Step 2: Incubation with Chemical Agents The collected red blood cells are then incubated with specific chemical agents or drugs suspected of causing an antibody response. This incubation allows for the interaction between the RBCs and the agents, facilitating the detection of any reactions that may indicate the presence of antibodies.
  • Step 3: Analysis of Reaction After the incubation period, the reaction between the red blood cells and the chemical agents is analyzed. This analysis is crucial for determining whether the drug is present in the bloodstream and if any antibodies are reacting with the RBCs.

3. Post-Procedure

Post-procedure care following the application of CPT® Code 86970 typically involves monitoring the patient for any immediate reactions, especially if the procedure is part of a transfusion process. The results of the antibody detection and compatibility testing will guide further clinical decisions, including whether to proceed with a blood transfusion or to consider alternative treatments. It is essential for healthcare providers to document the findings accurately and communicate any significant results to the patient and relevant medical staff to ensure safe and effective patient care.

Short Descr RBC PRETX INCUBATJ W/CHEMICL
Medium Descr PRETX RBC ANTIBODY INCUBAT W/CHEM AGNTS/DRUGS EA
Long Descr Pretreatment of RBCs for use in RBC antibody detection, identification, and/or compatibility testing; incubation with chemical agents or drugs, each
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator STV-Packaged Codes
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 235 - Other Laboratory
Date
Action
Notes
2013-01-01 Changed Short Descriptor changed.
1993-01-01 Added First appearance in code book in 1993.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"